Literature DB >> 21866554

Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.

Yin-He Wang1, Xiao-Dong Han, Yong Qiu, Jin Xiong, Yang Yu, Bin Wang, Ze-Zhang Zhu, Bang-Ping Qian, Yi-Xin Chen, Shou-Feng Wang, Hong-Fei Shi, Xu Sun.   

Abstract

BACKGROUND: The aim of this study was to investigate the association of insulin-like growth factor-1 receptor (IGF-1R) with metastasis and prognosis of osteosarcoma patients.
METHODS: RT-PCR and Western blot assays were performed to detect IGF-1R mRNA and protein expression in 26 osteosarcoma and noncancerous bone tissues. Immunohistochemistry was performed to analyze the correlation of IGF-1R expression in 84 osteosarcoma tissues with clinicopathological factors or survival of patients. Lentivirus-mediated RNA interference system was employed to downregulate IGF-1R expression and analyze the effects of IGF-1R downregulation on invasion and metastasis of osteosarcoma cells.
RESULTS: The relative levels of IGF-1R mRNA and protein expression were significantly higher in osteosarcoma tissues than in corresponding noncancerous bone tissues. The expression of IGF-1R protein was closely associated with surgical stage and distant metastasis of osteosarcoma patients. Osteosarcoma patients with high IGF-1R expression had poorer survival, and multivariate Cox analyses showed that high IGF-1R expression was an independent prognostic maker. Lentivirus-mediated targeting IGF-1R could significantly inhibit adhesion, migration, invasion, and metastasis of osteosarcoma cells, which might be correlated with of inactivation of Akt signaling pathway.
CONCLUSIONS: IGF-1R is an independent prognostic marker for osteosarcoma patients and increased expression of this molecular is correlated with metastasis of osteosarcoma.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866554     DOI: 10.1002/jso.22077

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  37 in total

1.  Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study.

Authors:  Scott C Borinstein; Donald A Barkauskas; Mark Bernstein; Allen Goorin; Richard Gorlick; Mark Krailo; Cindy L Schwartz; Leonard H Wexler; Jeffrey A Toretsky
Journal:  Pediatr Blood Cancer       Date:  2013-10-31       Impact factor: 3.167

2.  Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2.

Authors:  Feng Niu; Song Zhao; Chang-Yan Xu; Hui Sha; Gui-Bin Bi; Lin Chen; Long Ye; Ping Gong; Tian-Hong Nie
Journal:  Oncol Lett       Date:  2015-07-23       Impact factor: 2.967

3.  MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R.

Authors:  Guannan Wu; Jiayun Liu; Zhenfeng Wu; Xiaoyu Wu; Xuequan Yao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

4.  A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

Authors:  Lisa Mirabello; Roelof Koster; Branden S Moriarity; Logan G Spector; Paul S Meltzer; Joy Gary; Mitchell J Machiela; Nathan Pankratz; Orestis A Panagiotou; David Largaespada; Zhaoming Wang; Julie M Gastier-Foster; Richard Gorlick; Chand Khanna; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Ana Patiño-Garcia; Luis Sierrasesúmaga; Fernando Lecanda; Irene L Andrulis; Jay S Wunder; Nalan Gokgoz; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; Adrienne M Flanagan; Roberto Tirabosco; Maria Fernanda Amary; Dina Halai; Mandy L Ballinger; David M Thomas; Sean Davis; Donald A Barkauskas; Neyssa Marina; Lee Helman; George M Otto; Kelsie L Becklin; Natalie K Wolf; Madison T Weg; Margaret Tucker; Sholom Wacholder; Joseph F Fraumeni; Neil E Caporaso; Joseph F Boland; Belynda D Hicks; Aurelie Vogt; Laurie Burdett; Meredith Yeager; Robert N Hoover; Stephen J Chanock; Sharon A Savage
Journal:  Cancer Discov       Date:  2015-06-17       Impact factor: 39.397

Review 5.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

6.  microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.

Authors:  Ying Song; Yue Zhao; Xiangfu Ding; Xiaodong Wang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

7.  Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.

Authors:  Cheung-Kue Kim; Sunju Oh; Sook-Ja Kim; Sun-Hee Leem; Jeonghoon Heo; So-Hak Chung
Journal:  Genes Genomics       Date:  2017-12-01       Impact factor: 1.839

8.  Molecular alterations associated with osteosarcoma development.

Authors:  Kosei Ando; Kanji Mori; Franck Verrecchia; Baud'huin Marc; Françoise Rédini; Dominique Heymann
Journal:  Sarcoma       Date:  2012-02-15

9.  Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.

Authors:  Michael J Wagner; Robert G Maki
Journal:  Front Oncol       Date:  2013-02-04       Impact factor: 6.244

10.  Current therapeutic strategies and novel approaches in osteosarcoma.

Authors:  Kosei Ando; Marie-Françoise Heymann; Verena Stresing; Kanji Mori; Françoise Rédini; Dominique Heymann
Journal:  Cancers (Basel)       Date:  2013-05-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.